Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Colorectal Cancer With High Microsatellite Instability or Mismatched Repair Deficiency in Japan.
Saved in:
| Title: | Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Colorectal Cancer With High Microsatellite Instability or Mismatched Repair Deficiency in Japan. |
|---|---|
| Authors: | Taniguchi S; Division of Health Policy and Management, Department of Biomedical Science, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan., Moriwaki K; Division of Health Policy and Management, Department of Biomedical Science, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan; Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan University, Kyoto, Japan. Electronic address: moriken820318@gmail.com., Morimoto K; Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan University, Kyoto, Japan., Shimozuma K; Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan University, Kyoto, Japan. |
| Source: | Value in health regional issues [Value Health Reg Issues] 2025 Dec 10; Vol. 54, pp. 101555. Date of Electronic Publication: 2025 Dec 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101592642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-1102 (Electronic) Linking ISSN: 22121099 NLM ISO Abbreviation: Value Health Reg Issues Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41380627 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Colorectal Cancer With High Microsatellite Instability or Mismatched Repair Deficiency in Japan. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Taniguchi+S%22">Taniguchi S</searchLink>; Division of Health Policy and Management, Department of Biomedical Science, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan.<br /><searchLink fieldCode="AU" term="%22Moriwaki+K%22">Moriwaki K</searchLink>; Division of Health Policy and Management, Department of Biomedical Science, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan; Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan University, Kyoto, Japan. Electronic address: moriken820318@gmail.com.<br /><searchLink fieldCode="AU" term="%22Morimoto+K%22">Morimoto K</searchLink>; Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan University, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Shimozuma+K%22">Shimozuma K</searchLink>; Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan University, Kyoto, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101592642%22">Value in health regional issues</searchLink> [Value Health Reg Issues] 2025 Dec 10; Vol. 54, pp. 101555. <i>Date of Electronic Publication: </i>2025 Dec 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101592642 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2212-1102 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222121099%22">22121099 </searchLink><i>NLM ISO Abbreviation: </i>Value Health Reg Issues <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41380627 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vhri.2025.101555 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101555 Titles: – TitleFull: Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Colorectal Cancer With High Microsatellite Instability or Mismatched Repair Deficiency in Japan. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Taniguchi S – PersonEntity: Name: NameFull: Moriwaki K – PersonEntity: Name: NameFull: Morimoto K – PersonEntity: Name: NameFull: Shimozuma K IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 12 Text: 2025 Dec 10 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2212-1102 Numbering: – Type: volume Value: 54 Titles: – TitleFull: Value in health regional issues Type: main |
| ResultId | 1 |
